{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:08:51Z","timestamp":1789567731132,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.phrs.2022.106228","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T12:13:43Z","timestamp":1650543223000},"page":"106228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Mitochondrial stroke-like episodes: The search for new therapies"],"prefix":"10.1016","volume":"180","author":[{"given":"Daniele","family":"Orsucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Caldarazzo Ienco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Montano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106228_bib1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/jcm11030632","article-title":"Molecular genetics overview of primary mitochondrial myopathies","volume":"11","author":"Arena","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phrs.2022.106228_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2019.09.003","article-title":"Resolving complexity in mitochondrial disease: towards precision medicine","volume":"128","author":"Boggan","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.phrs.2022.106228_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrneurol.2013.126","article-title":"The clinical maze of mitochondrial neurology","volume":"9","author":"DiMauro","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2022.106228_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ene.13176","article-title":"Prediction of long-term prognosis by heteroplasmy levels of the m.3243A>G mutation in patients with the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome","volume":"24","author":"Fayssoil","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.phrs.2022.106228_bib5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/1873-3468.13995","article-title":"Mitochondrial disorders of the OXPHOS system","volume":"595","author":"Fernandez-Vizarra","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2022.106228_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1684\/epd.2010.0338","article-title":"Regression of stroke-like lesions in MELAS-syndrome after seizure control","volume":"12","author":"Finsterer","year":"2010","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.phrs.2022.106228_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2018.01.010","article-title":"8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease","volume":"123","author":"Ganetzky","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.phrs.2022.106228_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neurad.2021.02.002","article-title":"Major cerebral vessels involvement in patients with MELAS syndrome: Worth a scan? A systematic review","volume":"48","author":"Gramegna","year":"2021","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.phrs.2022.106228_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/jcm10010094","article-title":"Therapeutical management and drug safety in mitochondrial diseases-update 2020","volume":"10","author":"Gruosso","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phrs.2022.106228_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12630-011-9528-0","article-title":"Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: a case series","volume":"58","author":"Gurrieri","year":"2011","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.phrs.2022.106228_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/EBC20170114","article-title":"Emerging therapies for mitochondrial diseases","volume":"62","author":"Hirano","year":"2018","journal-title":"Essays Biochem."},{"key":"10.1016\/j.phrs.2022.106228_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2022.106228_bib13","first-page":"30191","article-title":"MITO-FIND: a study in 390 patients to determine a diagnostic strategy for mitochondrial disease","volume":"S1096\u20137192","author":"Kerr","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.phrs.2022.106228_bib14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"L-arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2022.106228_bib15","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/01.wnl.0000220197.36849.1e","article-title":"Endothelial dysfunction in MELAS improved by l-arginine supplementation","volume":"66","author":"Koga","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2022.106228_bib16","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s00415-018-9057-7","article-title":"Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research","volume":"265","author":"Koga","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2022.106228_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/nan.12238","article-title":"Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease","volume":"42","author":"Lax","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.phrs.2022.106228_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00062-018-0662-8","article-title":"Reversible dilation of cerebral macrovascular changes in MELAS episodes","volume":"29","author":"Li","year":"2019","journal-title":"Clin. Neuroradiol."},{"key":"10.1016\/j.phrs.2022.106228_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11011-006-9039-9","article-title":"Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA","volume":"22","author":"Lin","year":"2007","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.phrs.2022.106228_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.0b013e31827b1a2f","article-title":"High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation","volume":"80","author":"Malfatti","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2022.106228_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00415-013-7225-3","article-title":"The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender?","volume":"261","author":"Mancuso","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2022.106228_bib22","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ajmg.a.36725","article-title":"Novel MTCYB mutation in a young patient with recurrent stroke-like episodes and status epilepticus","volume":"164A","author":"Mancuso","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.phrs.2022.106228_bib23","first-page":"12","article-title":"Mitochondrial m.3243A > G mutation and carotid artery dissection","volume":"9","author":"Mancuso","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.phrs.2022.106228_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.12688\/wellcomeopenres.15599.1","article-title":"Consensus-based statements for the management of mitochondrial stroke-like episodes","volume":"4","author":"Ng","year":"2019","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.phrs.2022.106228_bib25","doi-asserted-by":"crossref","unstructured":"Y.S. Ng, N.Z. Lax, A.P. Blain, D. Erskine, M.R. Baker, T. Polvikoski, R.H. Thomas, C.M. Morris, M. Lai, R.G. Whittaker, A. Gebbels, A. Winder, J. Hall, C. Feeney, M.E. Farrugia, C. Hirst, M. Roberts, C. Lawthom, A. Chrysostomou, K. Murphy, T. Baird, P. Maddison, C. Duncan, J. Poulton, V. Nesbitt, M.G. Hanna, R.D.S. Pitceathly, R.W. Taylor, E.L. Blakely, A.M. Schaefer, D.M. Turnbull, R. McFarland, G.S. Gorman, Forecasting stroke-like episodes and outcomes in mitochondrial disease. Brain. 2022 Epub ahead of print. \u3008https:\/\/doi.org\/10.1093\/brain\/awab353\u3009.","DOI":"10.1093\/brain\/awab353"},{"key":"10.1016\/j.phrs.2022.106228_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-245898","article-title":"MELAS syndrome: an acute stroke-like episode complicated by renal tubular acidosis","volume":"14","author":"Ni Cathain","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.phrs.2022.106228_bib27","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212588","article-title":"Mitochondrial disorders and drugs: what every physician should know","volume":"8","author":"Orsucci","year":"2019","journal-title":"Drugs Context"},{"key":"10.1016\/j.phrs.2022.106228_bib28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/jcm10061249","article-title":"Mitochondrial syndromes revisited","volume":"10","author":"Orsucci","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phrs.2022.106228_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jimd.12185","article-title":"Incidence and predictors of total mortality in 267 adults presenting with mitochondrial diseases","volume":"43","author":"Papadopoulos","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.phrs.2022.106228_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.111.065722","article-title":"Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study","volume":"125","author":"Pappone","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2022.106228_bib31","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000339","article-title":"Systematic review and meta-analysis of cardiac involvement in mitochondrial myopathy","volume":"5","author":"Quadir","year":"2019","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.phrs.2022.106228_bib32","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2169\/internalmedicine.51.7529","article-title":"Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS","volume":"51","author":"Rikimaru","year":"2012","journal-title":"Intern. Med"},{"key":"10.1016\/j.phrs.2022.106228_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238224","article-title":"L-arginine effects on cerebrovascular reactivity, perfusion and neurovascular coupling in MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) syndrome","volume":"15","author":"Rodan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2022.106228_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ebcr.2019.01.008","article-title":"Perampanel: a therapeutic alternative in refractory status epilepticus associated with MELAS syndrome","volume":"11","author":"Santamarina","year":"2019","journal-title":"Epilepsy Behav. Case Rep."},{"issue":"11","key":"10.1016\/j.phrs.2022.106228_bib35","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1007\/s00415-021-10538-1","article-title":"Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection","volume":"268","author":"Sen","year":"2021","journal-title":"J. Neurol."},{"issue":"7262","key":"10.1016\/j.phrs.2022.106228_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature08368","article-title":"Mitochondrial gene replacement in primate offspring and embryonic stem cells","volume":"461","author":"Tachibana","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2022.106228_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.108111","article-title":"Neurological manifestations in m.3243A>G-related disease triggered by metformin","volume":"36","author":"Tong","year":"2022","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.phrs.2022.106228_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/NRL.0b013e318247bcd8","article-title":"Steroid responsive A3243G mutation MELAS: clinical and radiographic evidence for regional hyperperfusion leading to neuronal loss","volume":"18","author":"Walcott","year":"2012","journal-title":"Neurologist"},{"issue":"5","key":"10.1016\/j.phrs.2022.106228_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbagen.2011.04.018","article-title":"In vivo functional brain imaging and a therapeutic trial of l-arginine in melas patients","volume":"1820","author":"Yoneda","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2022.106228_bib40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/CM9.0000000000000061","article-title":"Levetiracetam administration is correlated with lower mortality in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes: a retrospective study","volume":"132","author":"Zhang","year":"2019","journal-title":"Chin. Med. J."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:31:16Z","timestamp":1760913076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"alternative-id":["S1043661822001736"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106228","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial stroke-like episodes: The search for new therapies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106228"}}